Old Web
English
Sign In
Acemap
>
authorDetail
>
Anupallavi Srinivasamani
Anupallavi Srinivasamani
Cancer research
Chemistry
PD-L1
blocking
Cytotoxic T cell
4
Papers
8
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
233 Human PD-L2 triggers a unique T cell inhibitory program through PD-1 engagement distinct from that of PD-L1
2021
Journal for ImmunoTherapy of Cancer
Anupallavi Srinivasamani
Michael A. Curran
Qinying Liu
Shwetha Hegde
Chao Hsien Chen
Kimal Rajapakshe
Cristian Coarfa
Show All
Source
Cite
Save
Citations (0)
Modified bispecific antibodies blocking both PD-L1 and PD-L2 engagement of PD-1 show higher ADCC potential and in vivo anti-tumor response
2021
Ashley Gelin
Coline Agnes Couillault
Anupallavi Srinivasamani
Qinying Liu
Michael A. Curran
Show All
Source
Cite
Save
Citations (0)
291 Dual-specific antibodies blocking both PD-L1 and PD-L2 engagement of PD-1 restore anti-tumor immunity
2021
Journal for ImmunoTherapy of Cancer
Coline Agnes Couillault
Anupallavi Srinivasamani
Shweta Hedge
Qinying Liu
Ashwin Jaiswal
Dongxing Zha
Michael A. Curran
Show All
Source
Cite
Save
Citations (0)
Mirc11 Disrupts Inflammatory but Not Cytotoxic Responses of NK Cells
2019
Cancer immunology research
Arash Nanbakhsh
Anupallavi Srinivasamani
Sandra L. Holzhauer
Matthew J. Riese
Yongwei Zheng
Demin Wang
Robert Burns
Michael Reimer
Sridhar Rao
Angela Lemke
Shirng-Wern Tsaih
Michael J. Flister
Shunhua Lao
Richard Dahl
Monica S. Thakar
Subramaniam Malarkannan
Show All
Source
Cite
Save
Citations (8)
1